Veru (VERU) filed separate registration statements late Tuesday with the US Securities and Exchange Commission for the sale of up to $200 million of its securities from time to time and 23.8 million shares of its common stock through the issuance of warrants.
The securities cover common and preferred stocks, debt securities, warrants, purchase contracts, rights and units, the company said.
Veru said it plans to use proceeds from the mixed-shelf and common stock offerings for general corporate purposes, including research and development and clinical trials.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments